• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高管理与贸易协定相关风险的监管能力。

Improving regulatory capacity to manage risks associated with trade agreements.

作者信息

Walls Helen L, Smith Richard D, Drahos Peter

机构信息

London School of Hygiene and Tropical Medicine, London, UK.

Leverhulme Centre for Integrative Research on Agriculture and Health, London, UK.

出版信息

Global Health. 2015 Mar 21;11:14. doi: 10.1186/s12992-015-0099-7.

DOI:10.1186/s12992-015-0099-7
PMID:25890343
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4376330/
Abstract

Modern trade negotiations have delivered a plethora of bilateral and regional preferential trade agreements (PTAs), which involve considerable risk to public health, thus placing demands on governments to strengthen administrative regulatory capacities in regard to the negotiation, implementation and on-going management of PTAs. In terms of risk management, the administrative regulatory capacity requisite for appropriate negotiation of PTAs is different to that for the implementation or on-going management of PTAs, but at all stages the capacity needed is expensive, skill-intensive and requires considerable infrastructure, which smaller and poorer states especially struggle to find. It is also a task generally underestimated. If states do not find ways to increase their capacities then PTAs are likely to become much greater drivers of health inequities. Developing countries especially struggle to find this capacity. In this article we set out the importance of administrative regulatory capacity and coordination to manage the risks to public health associated with PTAs, and suggest ways countries can improve their capacity.

摘要

现代贸易谈判催生了大量双边和区域优惠贸易协定(PTA),这些协定给公共卫生带来了相当大的风险,因此要求各国政府加强在PTA谈判、实施及持续管理方面的行政监管能力。在风险管理方面,PTA进行适当谈判所需的行政监管能力与PTA实施或持续管理所需的能力不同,但在所有阶段所需的能力都成本高昂、技能密集且需要大量基础设施,这对较小和较贫穷的国家来说尤其难以实现。这也是一项普遍被低估的任务。如果各国找不到提高自身能力的方法,那么PTA很可能会成为健康不平等加剧的更大推动因素。发展中国家尤其难以找到这种能力。在本文中,我们阐述了行政监管能力和协调对于管理与PTA相关的公共卫生风险的重要性,并提出了各国提高自身能力的方法。

相似文献

1
Improving regulatory capacity to manage risks associated with trade agreements.提高管理与贸易协定相关风险的监管能力。
Global Health. 2015 Mar 21;11:14. doi: 10.1186/s12992-015-0099-7.
2
The impact of preferential trade agreements on bilateral trade: A structural gravity model analysis.优惠贸易协定对双边贸易的影响:结构引力模型分析。
PLoS One. 2021 Mar 30;16(3):e0249118. doi: 10.1371/journal.pone.0249118. eCollection 2021.
3
Global trade and public health.全球贸易与公共卫生。
Am J Public Health. 2005 Jan;95(1):23-34. doi: 10.2105/AJPH.2004.038091.
4
The Regional Comprehensive Economic Partnership, Intellectual Property Protection, and Access to Medicines.《区域全面经济伙伴关系协定》、知识产权保护与药品可及性
Asia Pac J Public Health. 2016 Nov;28(8):682-693. doi: 10.1177/1010539516676338.
5
A new generation of trade policy: potential risks to diet-related health from the trans pacific partnership agreement.新一代贸易政策:跨太平洋伙伴关系协定对饮食相关健康的潜在风险。
Global Health. 2013 Oct 16;9:46. doi: 10.1186/1744-8603-9-46.
6
Policy space for health and trade and investment agreements.卫生与贸易及投资协定的政策空间。
Health Promot Int. 2014 Jun;29 Suppl 1:i29-47. doi: 10.1093/heapro/dau033.
7
Trade agreements and the risks for the nursing workforce, nursing practice and public health: A scoping review.贸易协定对护理劳动力、护理实践和公共卫生的风险:范围综述。
Int J Nurs Stud. 2020 Sep;109:103676. doi: 10.1016/j.ijnurstu.2020.103676. Epub 2020 Jun 7.
8
Monitoring the impacts of trade agreements on food environments.监测贸易协定对食品环境的影响。
Obes Rev. 2013 Oct;14 Suppl 1:120-34. doi: 10.1111/obr.12081.
9
Defending access to medicines in regional trade agreements: lessons from the Regional Comprehensive Economic Partnership - a qualitative study of policy actors' views.在区域贸易协定中捍卫药品可及性:区域全面经济伙伴关系的经验教训——政策行为者观点的定性研究。
Global Health. 2021 Jul 8;17(1):78. doi: 10.1186/s12992-021-00721-4.
10
Commentary: Moving towards policy coherence in trade and health.评论:迈向贸易与健康领域的政策协调一致。
J Public Health Policy. 2015 Nov;36(4):491-501. doi: 10.1057/jphp.2015.23. Epub 2015 Aug 6.

引用本文的文献

1
Public health advocacy strategies to influence policy agendas: lessons from a narrative review of success in trade policy.公共卫生倡导策略对影响政策议程的作用:从贸易政策成功案例的叙述性综述中得到的经验教训。
Global Health. 2023 Aug 23;19(1):60. doi: 10.1186/s12992-023-00960-7.
2
International investment liberalization, transnational corporations and NCD prevention policy non-decisions: a realist review on the political economy of tobacco, alcohol and ultra-processed food.国际投资自由化、跨国公司与非传染性疾病预防政策的不作为:烟草、酒精和超加工食品的政治经济学的现实主义述评。
Global Health. 2021 Nov 24;17(1):134. doi: 10.1186/s12992-021-00784-3.
3
Addressing Malnutrition: The Importance of Political Economy Analysis of Power.解决营养不良问题:权力的政治经济学分析的重要性。
Int J Health Policy Manag. 2021 Dec 1;10(12):809-816. doi: 10.34172/ijhpm.2020.250.
4
Corporate power and the international trade regime preventing progressive policy action on non-communicable diseases: a realist review.企业权力与国际贸易体制阻碍针对非传染性疾病采取渐进式政策行动:一项现实主义综述
Health Policy Plan. 2021 May 17;36(4):493-508. doi: 10.1093/heapol/czaa148.
5
Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts.分析贸易和投资协定对药品政策的影响:规定、途径和潜在影响。
Global Health. 2019 Nov 28;15(Suppl 1):78. doi: 10.1186/s12992-019-0518-2.
6
International trade and investment: still the foundation for tackling nutrition related non-communicable diseases in the era of Trump?国际贸易和投资:在特朗普时代,仍然是应对与营养相关的非传染性疾病的基础吗?
BMJ. 2019 Jun 4;365:l2217. doi: 10.1136/bmj.l2217.
7
Economic globalization, nutrition and health: a review of quantitative evidence.经济全球化、营养与健康:定量证据综述。
Global Health. 2019 Feb 20;15(1):15. doi: 10.1186/s12992-019-0456-z.
8
Trade, investment and public health: compiling the evidence, assembling the arguments.贸易、投资与公共卫生:汇集证据,形成观点。
Global Health. 2019 Jan 3;15(1):1. doi: 10.1186/s12992-018-0425-y.
9
The Trans Pacific Partnership Agreement, intellectual property and medicines: Differential outcomes for developed and developing countries.《跨太平洋伙伴关系协定》、知识产权与药品:发达国家和发展中国家的不同结果
Glob Soc Policy. 2018 Apr;18(1):7-27. doi: 10.1177/1468018117734153. Epub 2017 Oct 13.
10
Achieving universal health coverage in small island states: could importing health services provide a solution?在小岛屿国家实现全民健康覆盖:进口医疗服务能否提供解决方案?
BMJ Glob Health. 2018 Feb 19;3(1):e000612. doi: 10.1136/bmjgh-2017-000612. eCollection 2018.

本文引用的文献

1
Evolving trade policy and the Trans-Pacific Partnership Agreement: does it threaten Vietnam's access to medicine and its progress towards scaling up HIV prevention, treatment and care?不断演变的贸易政策与《跨太平洋伙伴关系协定》:它是否会威胁到越南获取药品的机会及其在扩大艾滋病毒预防、治疗和护理方面的进展?
Glob Public Health. 2015;10 Supppl 1:S149-60. doi: 10.1080/17441692.2014.981829. Epub 2014 Dec 3.
2
The Trans-Pacific Partnership agreement and public health: why we should be concerned.《跨太平洋伙伴关系协定》与公共卫生:我们为何应予以关注。
Open Med. 2014 Aug 12;8(3):e100-1. eCollection 2014.
3
The Trans Pacific Partnership Agreement: exacerbation of inequality for patients with serious mental illness.《跨太平洋伙伴关系协定》:加重严重精神疾病患者的不平等状况。
Aust N Z J Psychiatry. 2014 Dec;48(12):1077-80. doi: 10.1177/0004867414557679. Epub 2014 Oct 31.
4
Health concerns raised over EU-US trade deal.欧盟与美国贸易协定引发健康担忧。
Lancet. 2014 Sep 6;384(9946):843-4. doi: 10.1016/s0140-6736(14)61492-6.
5
Trade and investment liberalization and Asia's noncommunicable disease epidemic: a synthesis of data and existing literature.贸易与投资自由化及亚洲的非传染性疾病流行:数据与现有文献综述
Global Health. 2014 Sep 12;10:66. doi: 10.1186/s12992-014-0066-8.
6
Development, implementation and outcome of standards to restrict fatty meat in the food supply and prevent NCDs: learning from an innovative trade/food policy in Ghana.限制食品供应中高脂肪肉类和预防非传染性疾病的标准的制定、实施和结果:从加纳一项创新性的贸易/食品政策中吸取经验。
BMC Public Health. 2014 Mar 13;14:249. doi: 10.1186/1471-2458-14-249.
7
Pharmaceutical industry behaviour and the Trans Pacific Partnership Agreement.制药行业行为与《跨太平洋伙伴关系协定》
N Z Med J. 2014 Feb 14;127(1389):6-12.
8
How the Trans Pacific Partnership Agreement could undermine PHARMAC and threaten access to affordable medicines and health equity in New Zealand.《跨太平洋伙伴关系协定如何损害 PHARMAC 并威胁新西兰平价药品的可及性和医疗公平性》
Health Policy. 2013 Oct;112(3):227-33. doi: 10.1016/j.healthpol.2013.07.021. Epub 2013 Aug 30.
9
Trade secrets: will an EU-US treaty enable US big business to gain a foothold?商业机密:美欧条约会让美国大企业站稳脚跟吗?
BMJ. 2013 Jun 5;346:f3574. doi: 10.1136/bmj.f3574.
10
Emerging threats to public health from regional trade agreements.区域贸易协定对公共卫生构成的新威胁。
Lancet. 2013 Apr 27;381(9876):1507-9. doi: 10.1016/S0140-6736(13)60312-8. Epub 2013 Mar 1.